195 filings
Page 2 of 10
424B5
k5lnr
8 Jun 23
Prospectus supplement for primary offering
4:01pm
8-K
axm0ql9dm5p 84k0omf7
7 Jun 23
Departure of Directors or Certain Officers
4:24pm
424B5
llcf75 21
6 Jun 23
Prospectus supplement for primary offering
5:22pm
8-K
7vp4d 4vu
6 Jun 23
Other Events
4:03pm
8-K
j6garq vt6i
9 May 23
Cogent Biosciences Reports Recent Business Highlights and First Quarter
8:13am
ARS
m7q6efid9k
25 Apr 23
Annual report to shareholders
4:10pm
DEFA14A
3j0srb qbkfw
25 Apr 23
Additional proxy soliciting materials
4:06pm
S-8
7x0akz5 eo0
14 Mar 23
Registration of securities for employees
4:02pm
8-K
fka1dcr3z1q r17tob
14 Mar 23
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2022 Financial Results
8:21am
S-3ASR
xrglq 3vkfoeq3
10 Feb 23
Automatic shelf registration
4:57pm
8-K
hooep
12 Dec 22
Cogent Biosciences Announces Positive Updated Clinical Data from Ongoing Phase 2 APEX Trial Evaluating
8:03am
8-K
wrgbwn
14 Nov 22
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2022 Financial Results
7:14am
8-K
08vw0e7i hky
9 Aug 22
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2022 Financial Results
7:15am
8-K/A
xys2xss
16 Jun 22
Entry into a Material Definitive Agreement
5:03pm
8-K
l5iv1ml
15 Jun 22
Entry into a Material Definitive Agreement
5:18pm